Study: COPD patients on inhaled drugs more prone to pneumonia

11/26/2008 | Yahoo!

An analysis of 11 studies shows that patients with chronic obstructive pulmonary disease who used inhaled corticosteroids including GlaxoSmithKline's Flovent and AstraZeneca's Pulmicort had a 34% higher risk of developing pneumonia compared with those who did not. Researchers said it remains unclear how the treatments raise the risk and said the finding should not prompt patients to stop taking inhaled steroids.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT